Last reviewed · How we verify
NCT05639465
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
NA trial testing JoH-C19 in Emotional Distress in 800 participants. Currently enrolling.
15 May 2026
Quick facts
| Lead sponsor | University of Illinois at Urbana-Champaign |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 800 |
| Start date | 15 November 2022 |
| Primary completion | 15 May 2026 |
| Estimated completion | 15 May 2027 |
| Sites | 9 locations across United States |
Drugs / interventions tested
- JoH-C19
- Switch off Get Active
Conditions studied
- Emotional Distress — all drugs for Emotional Distress →
- Prosocial Behavior — all drugs for Prosocial Behavior →
- Pandemic, COVID-19 — all drugs for Pandemic, COVID-19 →
- Coping Skills — all drugs for Coping Skills →
Sponsor
University of Illinois at Urbana-Champaign
Who can join
Adults 8 to 14, any sex, with Emotional Distress or Prosocial Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Racial and ethnic minority children who live in socioeconomically disadvantaged communities are disproportionately impacted by pandemic and climate-induced disasters. Although effective interventions have been designed to treat mental health related symptoms in post-disaster settings, accessible, empirically supported prevention interventions are needed to prevent the onset of mental and behavioral health issues among these children. Building on our preliminary findings, the proposed study examines the efficacy and implementation of a COVID-19 adapted disaster focused prevention intervention, Journey of Hope-C19, in preventing behavioral health and interpersonal problems among racial and ethnic minority children who live in low-resource high poverty communities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05639465
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emotional Distress
Currently open trials in the same condition.
- NCT07436845 — Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arte · recruiting
- NCT06713460 — Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM) · NA · recruiting
- NCT05712057 — Neurostimulation Versus Therapy for Problems With Emotions · NA · recruiting
Other University of Illinois at Urbana-Champaign trials
Trials by the same sponsor.
- NCT07477067 — Exercise and Protein Efficiency in T2D · NA · recruiting
- NCT07367854 — Diet Synergy in Muscle Protein Synthesis · NA · not yet recruiting
- NCT07323862 — Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Thei · NA · not yet recruiting
- NCT07020741 — Stable Isotopes- Adults With Obesity · NA · recruiting
- NCT07167680 — Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05639465 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Urbana-Champaign
- Last refreshed: 23 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05639465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing